MicrosurgicalNCT07676916
Microsurgical Single Versus Double Dartos Flap in Distal Hypospadias Repair
A study testing Microsurgical Single Dartos Flap and Microsurgical Double Dartos Flap in people with Microsurgical and Single Dartos Flap, run by Tanta University at 1 site in Egypt.
Trial summary
This study aims to compare the surgical and functional outcomes of microsurgical single dartos flap versus double dartos flap in distal hypospadias repair. Read more about this study
- Who is it for?
- Ages 6 months to 18 years
- Conditions the study is for
- Microsurgical, Single Dartos Flap, Double Dartos Flap
- What is being tested?
- Microsurgical Single Dartos Flap and Microsurgical Double Dartos Flap
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 16 May 2026to 1 Apr 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 months to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Male patients diagnosed with Distal Hypospadias.
- Age: From 6 months to 18 years.
- Primary cases.
- Uretheral Plate>8mm.
- Glanular width≥14mm.
Who cannot join
- Coronal and glanular hypospadias.
- Severe chordee.
- Associated disorders of sexual development.
- Un-controlled bleeding disorders.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Tanta University
Tanta, El-Gharbia, 31527
Ahmed M Goda, MBBCH, 00201146341100, mamo.goda20@gmail.com
Mohamed R Taha, MD
About this study
Official title: Microsurgical Single Versus Double Dartos Flap in Distal Hypospadias Repair: A Prospective Randomized Trial
This study aims to compare the surgical and functional outcomes of microsurgical single dartos flap versus double dartos flap in distal hypospadias repair.
Read the detailed description
Hypospadias is recognized as a frequent congenital defect of the male urogenital system, with its prevalence exhibiting significant regional and ethnic disparities globally.
Despite continuous improvements in surgical methodology, the development of a urethrocutaneous fistula (UCF) remains a persistent and difficult postoperative challenge. Reported UCF rates fluctuate between 1% and over 20%, heavily influenced by factors such as the initial position of the meatus, the specific surgical approach, and the practitioner's level of expertise.
Expanding on the use of a single-layer dartos flap (SDF), recent research has focused on whether a double-layer dartos flap (DDF) provides enhanced protection against fistula formation.
- Being tested
- Microsurgical Single Dartos Flap, Microsurgical Double Dartos Flap
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Microsurgical Single Dartos FlapProcedure or surgery
Patients will undergo Microsurgical Single Dartos Flap.
Microsurgical Double Dartos FlapProcedure or surgery
Patients will undergo Microsurgical Double Dartos Flap.
| Study group | Role | What they receive |
|---|---|---|
| Group A | Experimental | Patients will undergo Microsurgical Single Dartos Flap. Receives: Procedure: Microsurgical Single Dartos Flap |
| Group B | Experimental | Patients will undergo Microsurgical Double Dartos Flap. Receives: Procedure: Microsurgical Double Dartos Flap |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of the Uethrocutaneous fistula
Incidence of the Uethrocutaneous fistula will be recorded.
Measured: 6 months after surgery
Secondary outcomes (4)
Incidence of the meatal stenosis
Incidence of the meatal stenosis will be recorded.
Measured: 6 months after surgery
Wound infection rate
Wound infection rate will be recorded.
Measured: 6 months after surgery
Cosmetic appearance
Cosmetic appearance will be recorded.
Measured: 6 months after surgery
Overall complication rate
Overall complication rate will be recorded.
Measured: 6 months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jun 2026
- Study start16 May 2026
- Primary completion1 Apr 2027 (estimated)
- Study completion1 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MicrosurgicalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Megahed Mohamed Goda, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07676916
- Sponsor's protocol ID
- 36265MS61/5/26
- Status last verified
- Jun 2026
- First submitted
- 24 Jun 2026
- Last updated
- 30 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.